Medicare Advantage Insurers Are Experiencing Unprecedented Headwinds

Medicare Advantage is facing unprecedented challenges from a decrease in reimbursement rates and the federal government’s scrutiny of insurer business practices.

$100,000 For Greenlanders Isn’t Much Compared To What Denmark Offers

A $100,000 lump sum payment to each Greenlander is worth far less than the lifetime value of remaining integrated within Denmark’s expansive welfare state.

Trump’s `Great Healthcare Plan’ Isn’t More Than A Brief Conceptual Outline

The White House released a healthcare framework as a call to action. It offers few specifics and raises more questions than answers on each point of the 1½-page plan.

Congressional Appropriations Bills Seek To Rein In PBMs: Here’s What To Know

Congressional appropriations package expands reporting obligations for PBMs to increase transparency. It also delinks PBM compensation in Medicare from list prices.

Medicare Negotiations For Next Round Of 15 Drugs Could Lead To Large Price Drops

A ceiling “maximum fair price” established by the Inflation Reduction Act will end up being an important driver of substantially lower prices for this round of 15 drugs.

It’s Unlikely Europe Will Raise Prescription Drug Prices

The Trump administration says that while it is pushing for lower prices in the U.S. drugmakers will be able to make up the difference by charging higher prices abroad.

How The Cold Void Of Space May Have Kick‑Started Life

Cold cosmic dust grains can link amino acids into protein‑like chains in deep space, suggesting life’s chemistry may begin long before planets form, seeding young worlds.

Super Agers’ Genetic Edge Keeps Their Minds Sharp

A protective APOE gene variant is enriched in Super Agers—people over 80 who think like 50‑year‑olds—cutting Alzheimer’s risk and helping preserve sharp memory into old age.

Five Extra Minutes A Day Could Add Years To Your Life

Just five extra minutes of daily activity plus small upgrades to sleep and diet can cut premature death risk and add healthy years, without extreme fitness goals.

Brighter Prospects For Huntington’s Disease

Experimental gene therapies like AMT‑130 lower toxic huntingtin protein and significantly slow Huntington’s disease, offering families new hope for longer, better quality lives.